Valuation dashboard for CONMED Corporation (CNMD) with P/E 25.01, P/B 1.27, EV/EBITDA 12.11 and dividend yield 0.45%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors.
Analysis Summary
CONMED Corporation reported revenue of $1.37B in the most recent fiscal year, growing at a 5-year CAGR of 9.8%. Net income reached $47.1M, with a 37.7% 5-year CAGR.
Trailing-twelve-month margins: gross margin 54.8%, operating margin 10.8%, net margin 4.1%.
At the current price of $47.33, CNMD trades at a P/E of 25.01 and an ROE of 5.51%. Market capitalisation stands at $1.4B.
Balance sheet quality for CNMD: current ratio of 2.1. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 25.01 |
| Price / Book | 1.27 |
| EV / EBITDA | 12.11 |
| Dividend Yield | 0.45% |
Valuation Models
| DCF Fair Value | $97.07 |
| vs Current Price | +105.1% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| CNMD | CONMED Corporation | $1.4B | 25.01 | 1.27 | 5.5% |
| NEOG | Neogen Corporation | $2.6B | 1.26 | -0.4% | |
| ABT | Abbott Laboratories | $168.7B | 31.35 | 3.33 | 12.5% |
| 0Y6X.L | Medtronic Plc | $118.6B | |||
| MDT | Medtronic plc | $110.6B | 21.28 | 2.20 | 9.7% |
| 0R2S.L | Stryker Corporation | $106.3B | 29.31 | 4.56 | 16.4% |
| SYK | Stryker Corporation | $105.6B | 28.54 | 4.40 | 14.5% |
| 0HOY.L | Boston Scientific Corporation | $65.0B |
Price
| Price | $47.33 |
| Market Cap | $1.4B |
| Exchange | NYSE |
| Country | US |
Profitability
| Return on Equity | 5.51% |
| Return on Invested Capital | 4.97% |
| Return on Assets | 2.46% |
| Gross Margin | 54.80% |
| Operating Margin | 10.79% |
| Net Margin | 4.12% |
Related companies: AHCO · AZTA · ESTA · INMD · KMTS · NEOG · NTLA
Explore sector: Healthcare · Medical - Devices
More sections of CNMD: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks